Walker et al., 2018 - Google Patents

Human and animal evidence of potential transgenerational inheritance of health effects: An evidence map and state-of-the-science evaluation

Walker et al., 2018

View PDF
Document ID
14450984981482658157
Author
Walker V
Boyles A
Pelch K
Holmgren S
Shapiro A
Blystone C
Devito M
Newbold R
Blain R
Hartman P
Thayer K
Rooney A
Publication year
Publication venue
Environment international

External Links

Snippet

Background An increasing number of reports suggest early life exposures result in adverse effects in offspring who were never directly exposed; this phenomenon is termed “transgenerational inheritance.” Given concern for public health implications for potential …
Continue reading at ntp.niehs.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345—Medical expert systems, neural networks or other automated diagnosis
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3431—Calculating a health index for the patient, e.g. for risk assessment

Similar Documents

Publication Publication Date Title
Walker et al. Human and animal evidence of potential transgenerational inheritance of health effects: An evidence map and state-of-the-science evaluation
Demeneix Evidence for prenatal exposure to thyroid disruptors and adverse effects on brain development
Nakamura et al. Proximodistal segregation of nonspatial information in CA3: preferential recruitment of a proximal CA3-distal CA1 network in nonspatial recognition memory
Arrindell Phobic dimensions: IV. The structure of animal fears
Conour et al. Preparation of animals for research—issues to consider for rodents and rabbits
Vandenberg et al. Plastic bodies in a plastic world: multi-disciplinary approaches to study endocrine disrupting chemicals
Lumley et al. Effects of a D1 antagonist and of sexual experience on copulation-induced Fos-like immunoreactivity in the medial preoptic nucleus
Dang et al. Fish embryo toxicity test, threshold approach, and moribund as approaches to implement 3R principles to the acute fish toxicity test
Beausoleil et al. Review of non‐monotonic dose‐responses of substances for human risk assessment
Gomes et al. Proactive common waxbills make fewer mistakes in a cognitive assay, the detour-reaching task
Varholick et al. Phenotypic variability between Social Dominance Ranks in laboratory mice
Achenbach et al. Comparison of the zebrafish embryo toxicity assay and the general and behavioral embryo toxicity assay as new approach methods for chemical screening
Harris et al. Identification of environmental chemicals targeting miscarriage genes and pathways using the comparative toxicogenomics database
Wachholz et al. From the farm to the lab: how chicken embryos contribute to the field of teratology
Rice et al. Cryptic sexual dimorphism in spatial memory and hippocampal oxytocin receptors in prairie voles (Microtus ochrogaster)
Miani et al. Autism spectrum disorder and prenatal or early life exposure to pesticides: A short review
EFSA Panel on Plant Protection Products and their Residues (EFSA PPR Panel) et al. Development of Integrated Approaches to Testing and Assessment (IATA) case studies on developmental neurotoxicity (DNT) risk assessment
Kimmel et al. Recent developments in regulatory requirements for developmental toxicology
Jang et al. Towards a strategic approaches in alternative tests for pesticide safety
Lipinski et al. Gene-environment interactions in birth defect etiology: Challenges and opportunities
Rosca et al. Impact of environmental neurotoxic: current methods and usefulness of human stem cells
Crowley-Perry et al. Zebrafish optomotor response and morphology are altered by transient, developmental exposure to bisphenol-A
Sun et al. Di-2-ethylhexyl phthalate induces heart looping disorders during zebrafish development
Overall Proceedings of the Dogs Trust Meeting on Advances in Veterinary Behavioural Medicine London; 4th–7th November 2004: Veterinary behavioural medicine: A roadmap for the 21st century
Kumar et al. Toxicity study of deflazacort on morphological development in zebrafish embryos